BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2 (original) (raw)

References

  1. Kantarjian, H.M., Deisseroth, A., Kurzrock, R., Estrov, Z. & Talpaz, M. Chronic myelogenous leukemia: a concise update. Blood 82, 691–703 (1993).
    CAS Google Scholar
  2. Gordon, M.Y. Biological consequences of the BCR-ABL fusion gene in humans and mice. J. Clin. Pathol. 52, 719–722 (1999).
    Article CAS Google Scholar
  3. Sawyers, C.L. Chronic myeloid leukemia. N. Engl. J. Med. 340, 1330–1340 (1999).
    Article CAS Google Scholar
  4. Carlesso, N., Frank, D.A. & Griffin, J.D. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by BCR-ABL. J. Exp. Med. 183, 811–820 (1996).
    Article CAS Google Scholar
  5. Perrotti, D. et al. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR-ABL-mediated leukemogenesis. EMBO J. 17, 4442–4455 (1998).
    Article CAS Google Scholar
  6. Ward, A.C., Loeb, D.M., Soede-Bobok, A.A., Touw, I.P. & Friedman, A.D. Regulation of granulopoiesis by transcription factors and cytokine signals. Leukemia 14, 973–990 (2000).
    Article CAS Google Scholar
  7. Orkin, S.H. Diversification of hematopoietic stem cells to specific lineages. Nature Rev. Genet. 1, 57–64 (2000).
    Article CAS Google Scholar
  8. Zhang, D. E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl Acad. Sci. USA 94, 569–574 (1997).
    Article CAS Google Scholar
  9. Radomska, H.S. et al. CCAAT enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18, 4301–4314 (1998).
    Article CAS Google Scholar
  10. Smith, L.T., Hohaus, S., Gonzalez, D.A., Dziennis, S.E. & Tenen, D.G. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony- stimulating factor receptor promoter in myeloid cells. Blood 88, 1234–1247 (1996).
    CAS Google Scholar
  11. Wang, X., Scott, E., Sawyers, C.L. & Friedman, A.D. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts. Blood 94, 560–571 (1999).
    CAS Google Scholar
  12. Scott, L.M., Civin, C.I., Rorth, P. & Friedman, A.D. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80, 1725–1735 (1992).
    CAS Google Scholar
  13. Cheng, T. et al. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc. Natl Acad. Sci. USA 93, 13158–13162 (1996).
    Article CAS Google Scholar
  14. Kozak, M. Initiation of translation in prokaryotes and eukaryotes. Gene 234, 187–208 (1999).
    Article CAS Google Scholar
  15. Lekstrom-Himes, J. & Xanthopoulos, K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273, 28545–28548 (1998).
    Article CAS Google Scholar
  16. Lincoln, A.J., Monczak, Y., Williams, S.C. & Johnson, P.F. Inhibition of CCAAT/enhancer-binding proteinα and β translation by upstream open reading frames. J. Biol. Chem. 273, 9552–9560 (1998).
    Article CAS Google Scholar
  17. Laneuville, P., Heisterkamp, N. & Groffen, J. Expression of the chronic myelogenous leukemia-associated p210BCR-ABL oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene 6, 275–282 (1991).
    CAS Google Scholar
  18. Steinman, R.A. & Tweardy, D.J. Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood 83, 119–127 (1994).
    CAS Google Scholar
  19. Tkatch, L.S., Rubin, K.A., Ziegler, S.F. & Tweardy, D.J. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J. Leukoc. Biol. 57, 964–971 (1995).
    Article CAS Google Scholar
  20. Lin, F.T., MacDougald, O.A., Diehl, A.M. & Lane, M.D. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein α message: transcriptional activator lacking antimitotic activity. Proc. Natl Acad. Sci. USA 90, 9606–9610 (1993).
    Article CAS Google Scholar
  21. Ossipow, V., Descombes, P. & Schibler, U. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl Acad. Sci. USA 90, 8219–8223 (1993).
    Article CAS Google Scholar
  22. Calkhoven, C.F., Muller, C. & Leutz, A. Translational control of C/EBPα and C/EBPβ isoforms expression. Genes Dev. 14, 1920–1932 (2000).
    CAS Google Scholar
  23. van der Velden, A.W. & Thomas, A.A. The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int. J. Biochem. Cell. Biol. 31, 87–106 (1999).
    Article Google Scholar
  24. Kozak, M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc. Natl Acad. Sci. USA 92, 2662–2666 (1995).
    Article CAS Google Scholar
  25. Ostareck-Lederer, A., Ostareck, D.H. & Hentze, M. W. Cytoplasmic regulatory functions of the KH-domain proteins hnRNP K and E1/E2. Trends Biochem. Sci. 23, 409–411 (1998).
    Article CAS Google Scholar
  26. Zou, X. & Calame, K. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J. Biol. Chem. 274, 18141–18144 (1999).
    Article CAS Google Scholar
  27. Zhang, D.E. et al. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr. Top. Microbiol. Immunol. 211, 137–147 (1996).
    CAS Google Scholar
  28. Bellon, T., Perrotti, D. & Calabretta, B. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter. Blood 90, 1828–1839 (1997).
    CAS Google Scholar
  29. Gaiger, A. et al. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood 86, 2371–2378 (1995).
    CAS Google Scholar
  30. Elmaagacli, A.H., Beelen, D.W., Opalka, B., Seeber, S. & Schaefer, U.W. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage. Annu. Hematol. 79, 424–431 (2000).
    Article CAS Google Scholar
  31. Kantarjian, H.M. et al. Chronic myelogenous leukemia in blast crisis: analysis of 242 patients. Am. J. Med. 83, 445–454 (1987).
    Article CAS Google Scholar
  32. Cambier, N., Chopra, R., Strasser, A., Metcalf, D. & Elefanty, A.G. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner. Oncogene 16, 335–348 (1998).
    Article CAS Google Scholar
  33. Issaad, C. et al. Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7. Leukemia 14, 662–670 (2000).
    Article CAS Google Scholar
  34. Pabst, T. et al. AML-1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia. Nature Med. 7, 444–451 (2001).
    Article CAS Google Scholar
  35. Wong, K.K et al. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15, 6535–6544 (1995).
    Article CAS Google Scholar
  36. Dai, Z. et al. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev. 12, 1415–1424 (1998).
    Article CAS Google Scholar
  37. Perrotti, D. et al. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CβII-dependent pathway. Mol. Cell. Biol. 20, 6159–6169 (2000).
    Article CAS Google Scholar
  38. Ilaria, R.L. Jr, Hawley, R.G. & Van Etten, R.A. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93, 4154–4166 (1999).
    CAS Google Scholar
  39. Cazzola, M. & Skoda, R.C. Translational pathophysiology: a novel molecular mechanism of human disease. Blood 95, 3280–3288 (2000).
    CAS Google Scholar
  40. Thisted, T., Lyakhov, D.L. & Liebhaber, S.A. Optimized RNA targets of two closely-related triple KH-domains proteins, hnRNP K and aCP-2KL, suggest distinct modes of RNA recognition. J. Biol. Chem. 276, 17484–17496 (2001).
    Article CAS Google Scholar
  41. Ostareck, D.H. et al. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89, 597–606 (1997).
    Article CAS Google Scholar
  42. Ostareck, D.H., Ostareck-Lederer, A., Shatsky, I.N. & Hentze, M.W. Lipoxygenase mRNA silencing in erythroid differentiation: the 3′ UTR regulatory complex controls 605 ribosomal subunit joining. Cell 104, 281–290 (2001).
    Article CAS Google Scholar
  43. Collier, B., Goobar-Larsson, L., Sokolowski, M. & Schwartz, S. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogeneous ribonucleoprotein K and Poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273, 22648–22656 (1998).
    Article CAS Google Scholar
  44. Blyn, L.B., Towner, J.S., Semler, B.L. & Ehrenfeld, E. Requirement of poly(rC)-binding protein 2 for translation of poliovirus RNA. J. Virol. 71, 6243–6246 (1997).
    CAS Google Scholar
  45. Silvera, D., Gamernik, A.V. & Andino, R. The N-terminal K homology domain of the poly(rC)-binding protein is a major determinant for binding to the poliovirus 5′ untranslated region and acts as an inhibitor of viral translation. J. Biol. Chem. 274, 38163–38170 (1999).
    Article CAS Google Scholar
  46. Graff, J., Cha, J., Blyn, L.B. & Ehrenfeld, E. Interaction of poly(rC)-binding protein 2 with the 5? noncoding region of hepatitis A virus RNA and its effects on translation. J. Virol. 72, 9668–9675 (1998).
    CAS Google Scholar
  47. Pabst, T. et al. Dominant-negative mutations of C/EBPα, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nature Genet. 27, 263–270 (2001).
    Article CAS Google Scholar
  48. Westendorf, J.J. et al. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol. 18, 322–333 (1999).
    Article Google Scholar
  49. Thomson, A.M., Rogers, J.T., Walker, C.E., Staton, J.M. & Leedman, P.J. Optimized RNA gel-shift and UV crosslinking assays for characterization of cytoplasmic RNA-protein interactions. Biotechniques 27, 1032–1039 (1999).
    Article Google Scholar
  50. Gamarnik, A.V. & Andino, R. Two functional complexes formed by KH domain containing proteins with the 5′ noncoding region of poliovirus RNA. RNA 3, 882–892 (1997).
    CAS Google Scholar

Download references